Data Licencing
Access context-rich patient data
Richly described multimodal patient data to meet your needs
Owkin’s data is different
13 Indications
Our products cover a range of cancer and I&I indications, as well as diagnostic specific datasets.
6 Modalities
Combine cutting-edge modalities to address problems that matter to you.
Richly described
Retain crucial information to contextualize the data, only possible through collaboration with our unrivalled academic network.
We provide high-quality, context-rich patient data that can be queried to understand it the way you need. Our direct partnerships with 100+ leading hospitals in 14 countries give us unparalleled deep data access - made possible through 9+ years of close engagement with clinicians and PIs.
This allows us to collect cutting-edge data modalities along with rich clinical characterization to build unmatched descriptions of each patient.
Example Cohort
Patient Count
664
Sample Count
504
Modalities
Clinical, H&E WSI
Geographic Origin
Switzerland, France, Germany, USA
Stage Distribution
I: 18%
II: 15%
III: 27%
IV: 40%
II: 15%
III: 27%
IV: 40%
Line of Therapy
1L: 52%
2L: 31%
3L+: 17%
2L: 31%
3L+: 17%
Median Age
1L: 52%
2L: 31%
3L+: 17%
2L: 31%
3L+: 17%
Age Range
34-89
Male %
59,1
Overall Survival Events
493
Progression Free Survival Events
487
Median Follow Up
38,4
Treatment Exposure
2L:31%
3L+:17%
2L:31%
3L+:17%
Chemo: 68%
IO:52%
Targeted: 41%
Rad: 29%
IO:52%
Targeted: 41%
Rad: 29%
IO-Treated Subset (n)
265
Biomarker Status
PD-L1+: 44%
EGFR-mut: 18%
ALK: 4%
EGFR-mut: 18%
ALK: 4%
Biomarker Method
PD-L1: Dako 22C3, SP263
Histological Subtypes
Adeno: 61%
Squamous: 28%
LCNEC: 5%
NOS: 6%
Squamous: 28%
LCNEC: 5%
NOS: 6%
Sample Collection Timepoint
Pre-treatment, Surgical resection
Select data cohort
Book a meeting
Book a meeting to discuss how our data can fit your needs and research goals.
AACR
Book a meeting at AACR
Are you going to be at AACR? Drop by Booth #4616 or book a time directly to discuss your data needs.
Book a meeting
